Take two aspirin ... ... and call the FDA
601140
For millions of Americans, the latest news is a great big pain in the neck, or maybe it&#39;s the shoulder. The Big Three of anti-inflammatory drugs - Vioxx, Celebrex and now Aleve - are believed to be potential health risks for patients.
79317
This has not been an especially good year for regulatory government agencies, with their accompanying acronyms. Let&#39;s begin with the Food and Drug Administration (FDA), which can&#39;t quite make up its mind which drug will kill us first - or how quickly.
153090
US health regulators are warning of heart risks connected to over-the-counter painkiller naproxen. The drug is sold as a generic and under several brand names, including
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
583813
It takes another run at getting FDA approval for its lead drug.
211731
The Food and Drug Administration on Thursday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
12098
Cleveland Clinic cardiologist Eric Topol was one of the first to point out the potential heart risk of Merck&#39;s (nyse: MRK - news - people ) withdrawn Vioxx and Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
665220
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis drug pulled from the market last week after a study suggested it doubled the risk of heart attacks and strokes.
414853
GAITHERSBURG, Md.  - The heart attack and stroke  risks linked to withdrawn arthritis drug Vioxx are an inherent  problem for similar pain pills, Vioxx maker Merck & Co. Inc.  told advisers to the U.S. Food and Drug Administration on  Wednesday.
131994
Doctors are struggling to decide which pain relievers to prescribe now that they know that drugs like Vioxx and Celebrex pose serious heart risks.
905
Two leading heart experts called for  urgent investigations on Wednesday into whether all painkilling  drugs known as COX-2 inhibitors may raise the risk of heart  attack in some people.
514972
Patients who were switched from the prescription pain reliever Vioxx, taken off the market in September, to Celebrex or Aleve want to know what they should do now that the safety of both alternatives is being questioned.
279290
A Food and Drug Administration panel tomorrow will consider one of the most urgent questions in medicine: what to do about the risk of blood clots caused by drug-coated stents, tiny medical devices implanted in the arteries of millions of people.
105508
Two leading heart experts called for urgent investigations on Wednesday into whether all painkilling drugs known as COX-2 inhibitors may raise the risk of heart attack in some people.
318859
WASHINGTON - With Vioxx off the market and heart-risk questions being raised about Celebrex and Aleve, what is someone who needs pain relief to do?
215788
One area physician wishes his patients would call to seek his advice before going cold turkey when it comes to three widely prescribed arthritis medications - Vioxx, Bextra and Celebrex.